Achillion - achillion.com : Achillion Pharmaceuticals: Home

2.50 Rating by ClearWebStats

achillion.com is 2 decades 4 years 3 months old. This website has a #1,059,313 rank in global traffic. It has a .com as an domain extension. This website has a Google PageRank of 5 out of 10. This domain is estimated value of $ 720.00 and has a daily earning of $ 3.00. While no active threats were reported recently by users, achillion.com is SAFE to browse.

Updated 9 years 2 months ago

Get Custom Widget

Traffic Report of Achillion

Daily Unique Visitors:	454
Daily Pageviews:	908

Estimated Valuation

Income Per Day:	$ 3.00
Estimated Worth:	$ 720.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	121

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Good
WOT Privacy:	Good
WOT Child Safety:	Not Applicable

Website Ranks & Scores

Google Pagerank:
Alexa Rank:	1,059,313
Domain Authority:	Not Applicable

Google Pagerank

PR 5 out of 10

PageSpeed Score

Siteadvisor Rating

Not Applicable

Where is achillion.com server located?

Hosted IP Address:

173.203.62.111

View other site hosted with achillion.com

Hosted Country:

Location Latitude:

41.85

Location Longitude:

-87.65

Social Engagement

Facebook Shares:	Not Applicable
Facebook Likes:	Not Applicable
Facebook Comments:	Not Applicable
Twitter Count (Tweets):	Not Applicable
Linkedin Shares:	Not Applicable
Delicious Shares:	Not Applicable

Page Resources Breakdown

Homepage Links Analysis

View achillion.com homepage link analysis

Page Title of Achillion

Achillion Pharmaceuticals: Home

Meta Description of Achillion

Headquartered in New Haven, CT, Achillion is a leading-edge pharmaceutical company advancing multiple candidates with proven mechanisms for the treatment of HCV and a novel complement factor D inhibitor platform. Hepatitis C is a worldwide epidemic affecting more than 150 million individuals. Complement-related diseases comprise a significant market opportunity.

Meta Tags of Achillion

achillion, hcv, pharmaceutical company, treatment of hcv, hepatitis c, news, events, sovaprevir, ach 3102, ach 2684, ach 3422, ns3 protease inhibitor, ns5a inhibitor, ns5b polymerase nucleotide inhibitor

Website Inpage Analysis

H1 Headings:	Not Applicable	H2 Headings:	6
H3 Headings:	3	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	41
Google Adsense:	Not Applicable	Google Analytics:	UA-26828474-1

Websites Hosted on Same IP (i.e. 173.203.62.111)

Array BioPharma :: Home

- arraybiopharma.com

Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.

1,389,310

$ 480.00

Cepheid | Cepheid - Delivering timely diagnostic information when it matters most.

- cepheid.com

Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. The advantages over other technologies are accuracy, speed, and ease-of-use — quickly getting important information into the hands of healthcare professionals to dramatically improve patient outcomes.

1,058,008

$ 720.00

Theravance Biopharma.: Home

- theravance.com

Theravance Biopharma is a biopharmaceutical company with one approved product, VIBATIV® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies.

1,170,231

$ 720.00

InSite Vision Incorporated - Home

- insitevision.com

InSite Vision develops products to treat a growing range of common eye problems: ocular infection, pain & inflammation in ocular surgery and glaucoma. Learn more

3,231,460

$ 240.00

Natera | Home

- natera.com

Natera is driven by a passion for elevating the science and utility of prenatal testing. From conception to delivery, Natera is pioneering next-generation accuracy and reliability. Learn more about our tests: Panorama™ Non-invasive Prenatal Testing, Genetic Carrier Screening (Natera One™), PGD/PGS Testing, Miscarriage Testing, and Prenatal Paternity Testing

502,726

$ 1,440.00

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Server: Apache
Vary: Accept-Encoding
Cache-Control: max-age=1
Content-Type: text/html; charset=ISO-8859-1
Content-Encoding: gzip
Date: Sun, 25 Jan 2015 01:58:16 GMT
Expires: Sun, 25 Jan 2015 01:58:17 GMT
Content-Length: 10038

Domain Information for achillion.com

Domain Registrar:	GODADDY.COM, LLC
Registration Date:	1999-12-16 2 decades 4 years 3 months ago
Last Modified:	2011-11-07 1 decade 2 years 5 months ago
Expiration Date:	2016-12-16 7 years 4 months 13 hours ago

Domain Nameserver Information

Host		IP Address	Country
auth01.ns.uu.net		198.6.1.81	United States
auth61.ns.uu.net		198.6.1.182	United States

DNS Record Analysis

Host	Type	TTL	Extra
achillion.com	A	3015	IP:173.203.62.111
achillion.com	NS	3599	Target:auth01.ns.uu.net
achillion.com	NS	3599	Target:auth61.ns.uu.net
achillion.com	SOA	3599	MNAME:auth01.ns.uu.net RNAME:hostmaster.uu.net Serial:22 Refresh:21600 Retry:3600 Expire:1728000
achillion.com	MX	3599	Priority:30 Target:achillion.com.s6b1.psmtp.com
achillion.com	MX	3599	Priority:40 Target:achillion.com.s6b2.psmtp.com
achillion.com	MX	3599	Priority:20 Target:achillion.com.s6a2.psmtp.com
achillion.com	MX	3599	Priority:10 Target:achillion.com.s6a1.psmtp.com